Antibodies that distinguish RANKL (RANK Ligand) can be utilized in a few logical applications, including Western Blot, ELISA, Flow Cytometry, Immunohistochemistry (Paraffin) and Immunocytochemistry. These antibodies target RANKL (RANK Ligand) in Human, Mouse and Rat tests. Our RANKL (RANK Ligand) monoclonal, polyclonal and recombinant monoclonal antibodies are created in Mouse, Rabbit, Rat and Goat. These antibodies have been checked by Neutralization to affirm explicitness to RANKL (RANK Ligand). Track down the RANKL (RANK Ligand) immunizer that meets your requirements. Look over 1 of 41 RANKL (RANK Ligand) antibodies, which have been approved in explores different avenues regarding 41 distributions and 75 pictures included in our information display.
Peruse essential antibodies for WB, Flow, IHC, ICC/IF, ELISA, IP, and different applications. Antibodies with Advanced Verification information have been approved for explicitness to guarantee that the neutralizer ties to the antigen expressed.
Target Information.
This quality encodes an individual from the cancer rot factor (TNF) cytokine family which is a ligand for osteoprotegerin and capacities as a critical element for osteoclast separation and enactment. This protein was demonstrated to be a dentritic cell endurance factor and is associated with the guideline of T cell-subordinate insusceptible reaction. White blood cell enactment was accounted for to prompt articulation of this quality and lead to an increment of osteoclastogenesis and bone misfortune.
This protein was displayed to enact antiapoptotic kinase AKT/PKB through a flagging complex including SRC kinase and growth rot factor receptor-related factor (TRAF) 6, which demonstrated this protein might play a part in the guideline of cell apoptosis. Designated disturbance of the connected quality in mice prompted extreme osteopetrosis and an absence of osteoclasts. The inadequate mice showed absconds in early separation of T and B lymphocytes, and neglected to frame lobulo-alveolar mammary designs during pregnancy. Two on the other hand joined record variations have been found.
Equivalent words
CD254; H-RANK-L; M-Rank-L; ODF; OPG ligand; OPGL; Osteoclast separation factor; Osteoprotegerin ligand; rank-l; RANKL; receptor activator of NF-kappaB ligand; receptor activator of atomic variable kappa B ligand; Receptor activator of atomic element kappa-B ligand; RP11-86N24.2; srankl; TNF-related actuation initiated cytokine; TRANCE; Tumor putrefaction factor ligand superfamily part 11; Tumor rot factor ligand superfamily part 11, layer structure; Tumor corruption factor ligand superfamily part 11, dissolvable structure; cancer rot factor-related enactment instigated cytokine.
CYTOKINE PROFILING ANTIBODY ARRAY.
Cytokine Profiling Antibody Array is a high-throughput ELISA based immune response cluster for protein articulation profiling of cytokines, chemokines and related biomarkers. The exhibit is intended for contrasting typical examples with treated or sick examples, and distinguishing applicant biomarkers.
KEY FEATURES
- 310 cytokine related antibodies; 6 reproduces per immune response
- Subjective/semi-quantitative protein articulation profiling of cytokines and related biomarkers
- Antibodies covalently immobilized on 3D polymer covered glass slide
- Fluorescent recognition.
RANKL Polyclonal Antibody
TNFSF11 encodes an individual from the cancer rot factor (TNF) cytokine family which is a ligand for osteoprotegerin and capacities as a critical variable for osteoclast separation and initiation. Growth corruption factor ligand superfamily part 11 was demonstrated to be a dentritic cell endurance factor and is engaged with the guideline of T cell-subordinate invulnerable reaction.
White blood cell actuation was accounted for to instigate articulation of this quality and lead to an increment of osteoclastogenesis and bone misfortune. This protein was displayed to enact antiapoptotic kinase AKT/PKB through a flagging complex including SRC kinase and cancer corruption factor receptor-related factor (TRAF) 6, which demonstrated this protein might play a part in the guideline of cell apoptosis.
Designated interruption of the connected quality in mice prompted extreme osteopetrosis and an absence of osteoclasts. The insufficient mice displayed absconds in early separation of T and B lymphocytes, and neglected to frame lobulo-alveolar mammary designs during pregnancy. Two then again grafted record variations have been found.
NFATc1 Polyclonal Antibody.
The result of NFATC1 is a part of the atomic variable of initiated T cells DNA-restricting record complex. This complicated comprises of somewhere around two parts: a prior cytosolic part that moves to the core upon T cell receptor (TCR) excitement, and an inducible atomic part.
RANKL Polyclonal Antibody |
|||
| 41789-100ul | SAB | 100ul | 302.4 EUR |
RANKL Polyclonal Antibody |
|||
| 41789-50ul | SAB | 50ul | 224.4 EUR |
RANKL Polyclonal Antibody |
|||
| ABP52325-003ml | Abbkine | 0.03ml | 189.6 EUR |
RANKL Polyclonal Antibody |
|||
| ABP52325-01ml | Abbkine | 0.1ml | 346.8 EUR |
RANKL Polyclonal Antibody |
|||
| ABP52325-02ml | Abbkine | 0.2ml | 496.8 EUR |
RANKL Polyclonal Antibody |
|||
| ABP53135-003ml | Abbkine | 0.03ml | 189.6 EUR |
RANKL Polyclonal Antibody |
|||
| ABP53135-01ml | Abbkine | 0.1ml | 346.8 EUR |
RANKL Polyclonal Antibody |
|||
| ABP53135-02ml | Abbkine | 0.2ml | 496.8 EUR |
Polyclonal RANKL Antibody |
|||
| APR00280G | Leading Biology | 0.1mg | 580.8 EUR |
RANKL Polyclonal Antibody |
|||
| ES3324-100ul | ELK Biotech | 100ul | 334.8 EUR |
RANKL Polyclonal Antibody |
|||
| ES3324-50ul | ELK Biotech | 50ul | 248.4 EUR |
RANKL Polyclonal Antibody |
|||
| ES4134-100ul | ELK Biotech | 100ul | 334.8 EUR |
RANKL Polyclonal Antibody |
|||
| ES4134-50ul | ELK Biotech | 50ul | 248.4 EUR |
RANKL antibody |
|||
| 70R-12312 | Fitzgerald | 100 ug | 483.6 EUR |
RANKL antibody |
|||
| 70R-12367 | Fitzgerald | 100 ug | 483.6 EUR |
RANKL Antibody |
|||
| 5318R-100 | Biovision | 379.2 EUR | |
RANKL Antibody |
|||
| 5318R-30T | Biovision | 175.2 EUR | |
RANKL antibody |
|||
| 70R-13199 | Fitzgerald | 100 ul | 548.4 EUR |
RANKL antibody |
|||
| 70R-13200 | Fitzgerald | 100 ul | 548.4 EUR |
Proteins having a place with this group of record factors assume a focal part in inducible quality record during safe reaction. The result of this quality is an inducible atomic part. It capacities as a significant atomic objective for the immunosuppressive medications, for example, cyclosporin A. Various on the other hand joined record variations encoding unmistakable isoforms have been distinguished for this quality. Different isoforms of this protein might manage inducible articulation of various cytokine qualities.